110 related articles for article (PubMed ID: 18305181)
21. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
22. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients.
Mehdipour P; Pirouzpanah S; Sarafnejad A; Atri M; Shahrestani ST; Haidari M
Cell Biol Int; 2009 Oct; 33(10):1050-6. PubMed ID: 19555767
[TBL] [Abstract][Full Text] [Related]
24. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).
Lazăr D; Tăban S; Dema A; Cornianu M; Goldiş A; Raţiu I; Sporea I
Rom J Morphol Embryol; 2009; 50(1):41-50. PubMed ID: 19221644
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
26. MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer.
Wang L; Yin F; Du Y; Du W; Chen B; Zhang Y; Wu K; Ding J; Liu J; Fan D
Am J Clin Pathol; 2009 Jun; 131(6):793-801. PubMed ID: 19461085
[TBL] [Abstract][Full Text] [Related]
27. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
28. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
[TBL] [Abstract][Full Text] [Related]
29. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
30. Tumor-specific hyperactive low-molecular-weight cyclin E isoforms detection and characterization in non-metastatic colorectal tumors.
Corin I; Di Giacomo MC; Lastella P; Bagnulo R; Guanti G; Simone C
Cancer Biol Ther; 2006 Feb; 5(2):198-203. PubMed ID: 16397408
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer.
Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
[TBL] [Abstract][Full Text] [Related]
32. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
33. Lower- and higher-grade subtypes of diffuse gastric cancer.
Chiaravalli AM; Klersy C; Tava F; Manca R; Fiocca R; Capella C; Solcia E
Hum Pathol; 2009 Nov; 40(11):1591-9. PubMed ID: 19540560
[TBL] [Abstract][Full Text] [Related]
34. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
Chatterjee D; Sabo E; Tavares R; Resnick MB
Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
37. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
38. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers.
Zhou F; Xu Y; Shi J; Lan X; Zou X; Wang L; Huang Q
Cancer Med; 2016 Dec; 5(12):3403-3411. PubMed ID: 27781410
[TBL] [Abstract][Full Text] [Related]
39. Cyclin E is a more powerful predictor of breast cancer outcome than proliferation.
Keyomarsi K; Tucker SL; Bedrosian I
Nat Med; 2003 Feb; 9(2):152. PubMed ID: 12563321
[No Abstract] [Full Text] [Related]
40. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
Kim JH; Kim MA; Lee HS; Kim WH
Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
